The Spot Sign and Tranexamic Acid on Preventing ICH Growth – AUStralasia Trial (STOP-AUST): Protocol of a Phase II Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
Atte Meretoja(University of Helsinki), Stephen M. Davis(The Royal Melbourne Hospital), Leonid Churilov(The University of Melbourne), Harshal Nandurkar(St Vincent's Hospital Melbourne), Christopher Levi(John Hunter Hospital), Nawaf Yassi, Bernard Yan(Centre hospitalier universitaire d'Orléans), Tissa Wijeratne(Sunshine Hospital), Jorge A. Zavala(University of Massachusetts Amherst), Jayantha Rupasinghe(Frankston Hospital), Timothy Kleinig(Royal Adelaide Hospital), Richard I. Aviv(Ottawa Hospital), Christen Barras(The University of Melbourne), Geoffrey A. Donnan(The Royal Melbourne Hospital), Candice Delcourt(University of Leicester), Chris Bladin(Box Hill Hospital), Neil Mahant(MACOM (United States)), Neil J. Spratt, Peter Mitchell(The Royal Melbourne Hospital), Bruce Campbell(The Royal Melbourne Hospital), Mark Parsons(UNSW Sydney), Andrew Lee(Flinders University), Romesh Markus(MACOM (United States)), Jim Jannes(Royal Adelaide Hospital), Jonathan Sturm(MACOM (United States)), Craig S. Anderson(Royal Prince Alfred Hospital)
Cited by 73
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
|New England Journal of Medicine|2015|5.8k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k